Coupling GFAP levels with other inflammatory and/or cardiometabolic biomarkers could enhance detection of LVO stroke with favorable imaging, which in turn, could improve triage trajectories directly to comprehensive stroke centers with endovascular capabilities (17, 18), especially in resource-limited settings (19). The gene discussed is GFAP; the disease is Stroke.